An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer

por Peled, Nir, Fuchs, Vered, Kestenbaum, Emily H, Oscar, Elron, Bitran, Raul
Publicado 2021

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases

por Goldstein, Iris M, Roisman, Laila C, Keren-Rosenberg, Shoshana, Dudnik, Julia, Nechushtan, Hovav, Shelef, Ilan, Fuchs, Vered, Kian, Waleed, Peled, Nir
Publicado 2020

Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer

por Roisman, Laila C., Kian, Waleed, Anoze, Alaa, Fuchs, Vered, Spector, Maria, Steiner, Roee, Kassel, Levi, Rechnitzer, Gilad, Fried, Iris, Peled, Nir, Bogot, Naama R.
Publicado 2023

Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)

por Shalata, Walid, Iraqi, Muhammed, Bhattacharya, Baisali, Fuchs, Vered, Roisman, Laila C., Cohen, Ahron Yehonatan, Massalha, Ismaell, Yakobson, Alexander, Prasad, Manu, Elkabets, Moshe, Porgador, Angel, Peled, Nir
Publicado 2021

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study

por Peled, Nir, Kian, Waleed, Inbar, Edna, Goldstein, Iris M, Zemel, Melanie, Rotem, Ofer, Rozenblum, Anna B, Nechushtan, Hovav, Dudnik, Elizabeth, Levin, Daniel, Zer, Alona, Keren-Rosenberg, Shoshana, Yust-Katz, Shlomit, Fuchs, Vered, Remilah, Areen A, Shelef, Ilan, Roisman, Laila C
Publicado 2021